Extra blood test could help detect risk of death from heart attack

pharmafile | February 23, 2022 | News story | Research and Development  

Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of dying in the next three years, according to the BBC.

The test, for the C-reactive protein (CRP), helps detect inflammation, and is already being used in hospitals to diagnose other conditions. This test could help doctors decide which patients may need more aggressive treatment and closer monitoring. The National Heart and Lung Institute says that this could help save many lives.

Currently, doctors test for the troponin protein, released into the blood stream when the heart is damaged, according to the British Heart Foundation (BHF), which funded the research.

Scientists at the National Heart and Lung Institute, and the National Institute for Health Research Health Informatics Collaborative used data from more than 250,000 patients admitted to hospital with a suspected heart attack, to support that CRP tests provide a more detailed picture.

Moving forward, researchers hope to test the anti-inflammatory drug colchicine, found to be effective against atherosclerosis (a build-up of fatty deposits in the arteries that increases the chance of a heart attack), on patients with high CRP levels.

Leader of the research, cardiologist Dr Ramzi Khamis, said “The CRP test is not in the guidelines for a suspected heart attack yet – and therefore is not routinely ordered when a patient presents with a suspected heart attack. It may get proposed for consideration to be included in future European Society of Cardiologists or NICE guidelines, which would take all the data into account before issuing a recommendation for its routine use.”

Lina Adams

Related Content

No items found

Latest content